机构:[1]Hebei Clinical Research Center for Chronic Kidney Disease, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Department of Nephrology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, PR China临床科室肾内科河北医科大学第四医院
This work was supported by The Project of Hebei Clinical Medicine Outstanding Personnel Training (grant. no. 2019139), Hebei province medical technology tracking project (G2018050) and Hebei province Key research and development Project (20377704D).
第一作者机构:[1]Hebei Clinical Research Center for Chronic Kidney Disease, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Department of Nephrology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, PR China
通讯作者:
通讯机构:[1]Hebei Clinical Research Center for Chronic Kidney Disease, Hebei Key Laboratory of Vascular Calcification in Kidney Disease, Department of Nephrology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, PR China[*1]Department of Nephrology, the Fourth Hospital of Hebei Medical University, 12 Jiankang Road, Shijiazhuang 050011, PR China.
推荐引用方式(GB/T 7714):
Feng Qingyan,Cheng Meijuan,Jin Jingjing,et al.DRAM1 plays a tumor suppressor role in clear cell renal cell carcinoma through modulating Akt signaling.[J].ACTA HISTOCHEMICA.2022,124(3):doi:10.1016/j.acthis.2022.151874.
APA:
Feng Qingyan,Cheng Meijuan,Jin Jingjing,Zhang Shenglei,Bai Yaling&Xu Jinsheng.(2022).DRAM1 plays a tumor suppressor role in clear cell renal cell carcinoma through modulating Akt signaling..ACTA HISTOCHEMICA,124,(3)
MLA:
Feng Qingyan,et al."DRAM1 plays a tumor suppressor role in clear cell renal cell carcinoma through modulating Akt signaling.".ACTA HISTOCHEMICA 124..3(2022)